LBA27A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment

LBA27A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 29; no. suppl_8
Main Authors: Qin, S K, Ren, Z G, Meng, Z Q, Chen, Z D, Chai, X L, Xiong, J P, Bai, Y X, Yang, L, Zhu, H, Fang, W J, Lin, X Y, Chen, X M, Li, E X, Xia, Y, Zou, J J
Format: Journal Article
Language:English
Published: Oxford University Press 01-10-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy424.029